K062994 is an FDA 510(k) clearance for the LATERALIZED TAPERLOC MICROPLASTY FEMORAL COMPONENTS. This device is classified as a Prosthesis, Hip, Semi-constrained (metal Uncemented Acetabular Component) (Class III - Premarket Approval, product code KWA).
Submitted by Biomet Manufacturing Corp (Warsaw, US). The FDA issued a Cleared decision on March 9, 2007, 158 days after receiving the submission on October 2, 2006.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3330.